Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 1
1977 6
1978 1
1979 1
1980 2
1981 3
1982 1
1983 4
1985 3
1986 2
1987 5
1988 2
1989 2
1990 2
1991 9
1992 4
1993 3
1994 2
1995 5
1996 3
1997 4
1998 1
1999 4
2000 2
2001 1
2003 2
2005 3
2007 4
2008 6
2009 11
2010 4
2011 1
2013 3
2014 2
2015 1
2016 3
2017 4
2018 2
2019 1
2020 1
2021 6
2022 6
2023 3
2024 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Proximal versus distal protection: dissecting clinical trials.
Fioretti V, Gerardi D, Luzi G, Stabile E. Fioretti V, et al. Among authors: luzi g. Minerva Cardiol Angiol. 2022 Dec;70(6):727-737. doi: 10.23736/S2724-5683.22.06233-0. Minerva Cardiol Angiol. 2022. PMID: 36700668 Free article. Review.
Intravenous IgG: biological modulating molecules.
Luzi G, Bongiorno F, Paparo Barbaro S, Bruno G. Luzi G, et al. J Biol Regul Homeost Agents. 2009 Jan-Mar;23(1):1-9. J Biol Regul Homeost Agents. 2009. PMID: 19321040
Risk Score for Prediction of Dialysis After Transcatheter Aortic Valve Replacement.
Pasceri V, Pelliccia F, Mehran R, Dangas G, Porto I, Radico F, Biancari F, D'Ascenzo F, Saia F, Luzi G, Bedogni F, Amat Santos IJ, De Marzo V, Dimagli A, Mäkikallio T, Stabile E, Blasco-Turrión S, Testa L, Barbanti M, Tamburino C, Fabiocchi F, Chilmeran A, Conrotto F, Costa G, Stefanini G, Spaccarotella C, Macchione A, La Torre M, Bendandi F, Juvonen T, Wańha W, Wojakowski W, Benedetto U, Indolfi C, Hildick-Smith D, Zimarino M. Pasceri V, et al. Among authors: luzi g. J Am Heart Assoc. 2024 Apr 2;13(7):e032955. doi: 10.1161/JAHA.123.032955. Epub 2024 Mar 27. J Am Heart Assoc. 2024. PMID: 38533944 Free PMC article.
Vitamin D and cardiovascular disease risk. A literature overview.
Cortese F, Costantino MF, Luzi G, Di Marino S, Giordano P, Monitillo F. Cortese F, et al. Among authors: luzi g. Mol Biol Rep. 2022 Sep;49(9):8925-8942. doi: 10.1007/s11033-022-07373-6. Epub 2022 Apr 1. Mol Biol Rep. 2022. PMID: 35364717 Review.
The role of telemetry in perinatal monitoring.
Di Renzo GC, Luzi G, Caserta G, Clerici G, Cosmi EV. Di Renzo GC, et al. Among authors: luzi g. J Perinat Med. 1994;22(6):517-22. J Perinat Med. 1994. PMID: 7674106 Review.
[An atrial myxoma with a significant coronary vascularization].
Cortese F, Costantino MF, Stabile E, D'Addeo G, Bochicchio A, Luzi G. Cortese F, et al. Among authors: luzi g. G Ital Cardiol (Rome). 2022 Nov;23(11):876-877. doi: 10.1714/3900.38827. G Ital Cardiol (Rome). 2022. PMID: 36300391 Italian. No abstract available.
139 results